Available Technology


The Center for Disease Control and Prevention (CDC) has developed a list of pathogens. These are classified into three categories: A, B, and C. It is important from a national security perspective to develop a means of identifying these organisms. A key element in developing defenses against uses of such pathogens by rogue entities is the ability to quickly and accurately detect the presence of these organisms in samples or environment. DNA-based diagnostic methods are only valuable if they are highly specific to the target organism, otherwise, they may give rise to false positive results. False positives are particularly an issue when analyzing complex environmental samples where nontarget microbes cross-react with the target organism. A reliable and specific DNA-based diagnostic method is thus needed for the detection of these pathogens.

LLNL researchers have discovered unique DNA signatures that can be used to identify, with high specificity, three such organisms, including Yersinia pestis and Francisella tularensis (both Category A agents), and Brucella species (Category B agent). The DNA sequence information of a desired region of an organism unique to that organism is recorded, a DNA primer is used to amplify the target fragment using the polymerase chain reaction (PCR), and then a hybridization probe is used to increase the specificity of the detection process by marking the target. Combined, this process uniquely identifies a DNA signature of an organism.

Patent Abstract: 

Lawrence Livermore National Laboratory (LLNL), operated by the Lawrence Livermore National Security (LLNS), LLC under contract no. DE-AC52-07NA27344 (Contract 44) with the U.S. Department of Energy (DOE), is offering the opportunity to secure a license to exercise patent rights for commercializing its pathogen specific DNA diagnostic methods technology.


• Simple and accurate DNA-based diagnostics • Specific diagnostic results even with complex environmental samples


• Accurate detection of select pathogens belonging to Category A (Yersinia pestis and Francisella tularensis) and category B (Brucella species) in environmental samples for surveillance purpose • Identification of unique regions which may be targets for protein-based diagnostics and research

Patent Number: 
7,494,772; 7,494,773; 7,494,778
Technology Type(s): 
Medical Diagnostics
Internal Laboratory Ref #: 
Patent Status: 
3 Issued Patents
Patent Issue Date: 
February 24, 2009
Lab Representatives
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin